Profile data is unavailable for this security.
About the company
Philip Morris International Inc. (PMI) is an international tobacco company. The Company focuses on delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its product portfolio consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. It is engaged in developing smoke-free products for adults along with building scientific assessment capabilities in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Versions of PMI's IQOS Platform 1 devices and consumables have been authorized by the U.S. Food and Drug Administration as Modified Risk Tobacco Products (MRTPs). Its portfolio consists of both international and local brands and is led by Marlboro. The Company's other cigarette brands include Bond Street, Chesterfield, L&M, Lark and Philip Morris.
- Revenue in USD (TTM)31.80bn
- Net income in USD9.06bn
- LocationPhilip Morris International Inc120 Park AveNEW YORK 10017-5577United StatesUSA
- Phone+1 (917) 663-2000
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|PM:NYQ since |
|Swedish Match AB- Cigarette Business||Announced||15 Sep 2021||15 Sep 2021Announced||-4.28%||--|
|OtiTopic Inc||Deal completed||09 Aug 2021||09 Aug 2021Deal completed||-1.62%||--|